Brain Sciences (Dec 2022)

The Discourse Profile in Corticobasal Syndrome: A Comprehensive Clinical and Biomarker Approach

  • Isabel Junqueira de Almeida,
  • Marcela Lima Silagi,
  • Maria Teresa Carthery-Goulart,
  • Jacy Bezerra Parmera,
  • Mario Amore Cecchini,
  • Artur Martins Coutinho,
  • Sonia Maria Dozzi Brucki,
  • Ricardo Nitrini,
  • Eliane Schochat

DOI
https://doi.org/10.3390/brainsci12121705
Journal volume & issue
Vol. 12, no. 12
p. 1705

Abstract

Read online

The aim of this study was to characterize the oral discourse of CBS patients and to verify whether measures obtained during a semi-spontaneous speech production could differentiate CBS patients from controls. A second goal was to compare the performance of patients with CBS probably due to Alzheimer’s disease (CBS-AD) pathology and CBS not related to AD (CBS-non-AD) in the same measures, based on the brain metabolic status (FDG-PET) and in the presence of amyloid deposition (amyloid-PET). Results showed that CBS patients were significantly different from controls in speech rate, lexical level, informativeness, and syntactic complexity. Discursive measures did not differentiate CBS-AD from CBS-non-AD. However, CBS-AD displayed more lexical-semantic impairments than controls, a profile that is frequently reported in patients with clinical AD and the logopenic variant of primary progressive aphasia (lvPPA). CBS-non-AD presented mainly with impairments related to motor speech disorders and syntactic complexity, as seen in the non-fluent variant of PPA.

Keywords